Central Drugs Standard Control Organisation
Indian Apex Drug Regulatory Body
Central Drugs Standard Control Organisation ▸ Facts ▸ Comments ▸ News ▸ Videos
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices. It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union. The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO).
| 0 shares | ShareTweetSavePostSend |
You Might Like
Bring health supplements under drug control watch, suggests panelAn inter-ministerial committee has recommended that health supplements claiming to cure or mitigate diseases be classified as drugs. This shift aims to increase regulatory oversight by bringing these..IndiaTimes - Published | |
Centre's lens on unapproved antibiotic combos, asks states to monitor availabilityCentre requests states for licensed antibiotics. Study finds banned drugs still sold, with sales rising. Pharma firms promote new components to bypass rules, impacting resistance. CDSCO banned 26..IndiaTimes - Published | |
Astra Zeneca gets nod for anticoagulant drugAstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses..IndiaTimes - Published | |
AstraZeneca gets CDSCO nod for drug to treat biliary tract cancerIndiaTimes - Published | |
World's first intranasal Covid vaccine from Bharat Biotech gets CDSCO approvaliNCOVACC: Bharat Biotech said that launch dates, pricing and availability will be announced in due course of time.DNA - Published | |
Bharat Biotech's intranasal Covid-19 vaccine iNCOVACC gets CDSCO nod for heterologous booster dosesIndiaTimes - Published | |
Deaths in Gambia due to India-made cough syrups: Centre takes steps to curb damage, Haryana firm remains non-operationalCentral Drugs Standard Control Organisation (CDSCO) launched an inquiry and alerted Haryana last week after learning about the Gambia tragedy.DNA - Published | |
Firm behind Gambia child deaths a repeat offender in IndiaThe Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold locally in India, but the same company,..IndiaTimes - Published | |
Drug regulator launches probe on WHO alert over deaths in Gambia linked to India-made cough syrups: ReportThe CDSCO said it responded to the WHO within an hour-and-a-half after receiving intimation.DNA - Published | |
CDSCO grants EUA to Bharat Bio's intranasal Covid-19 vaccineThe Central Drugs Standard Control Organisation (CDSCO) has granted approval to BBV154 for restricted use in emergency situation, Union health minister Dr Mansukh Mandaviya announced via a tweet on..IndiaTimes - Published | |
Zenara Pharma gets CDSCO nod to manufacture Covid drugIndiaTimes - Published | |
Hyd-based Zenara Pharma gets CDSCO nod to make generic version of Pfizer's Covid-19 pillIndiaTimes - Published | |
Biocon executive among 5 held in 'bribery' caseThe CBI on Tuesday arrested three persons including L Praveen Kumar, associate vice president and head-national regulatory affairs of Bengaluru-based Biocon Biologics Limited, a company founded by..IndiaTimes - Published | Expert panel recommends Corbevax Covid jab for 5-12 years age groupBiological Eβs Covid-19 vaccine, Corbevax, is likely to get an emergency-use authorisation (EUA) for use in children in the 5-12 years age bracket following recommendations from the subject expert..IndiaTimes - Published |
Serum Institute has applied for full market authorisation of Covishield: CEO Adar PoonawalaSerum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla..IndiaTimes - Published | Bio E's Corbevax, SII's Covovax & antiviral drug Molnupiravir get EUA nodIn a significant boost for Indiaβs fight against Covid-19, the Central Drugs Standard Control Organisation (CDSCO) has granted emergency use authorisation for two more Covid-19 vaccines β Corbevax..IndiaTimes - Published |
CDSCO panel recommends emergency use authorisation for SII's Covid vaccine CovovaxIndiaTimes - Published | CDSCO panel seeks local clinical trial data from SII for approval of Covishield as booster doseIndiaTimes - Published |
